RT Journal Article
SR Electronic
T1 COVID-19 Transmission Within Danish Households: A Nationwide Study from Lockdown to Reopening
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.09.20191239
DO 10.1101/2020.09.09.20191239
A1 Lyngse, Frederik Plesner
A1 Kirkeby, Carsten Thure
A1 Halasa, Tariq
A1 Andreasen, Viggo
A1 Skov, Robert Leo
A1 Møller, Frederik Trier
A1 Krause, Tyra Grove
A1 Mølbak, Kåre
YR 2020
UL http://medrxiv.org/content/early/2020/09/09/2020.09.09.20191239.abstract
AB Background The Covid-19 pandemic is one of the most serious global public health threats in recent times. Understanding transmission of SARS-CoV-2 is of utmost importance to be able to respond to outbreaks and take action against spread of the disease. Transmission within the household is a concern, especially because infection control is difficult to apply within the household domain.Methods We used comprehensive administrative register data from Denmark, comprising the full population and all COVID-19 tests, to estimate household transmission risk and attack rate.Results We studied the testing dynamics for COVID-19 and found that the day after receiving a positive test result within the household, 35% of potential secondary cases were tested and 13% of these were positive. After a primary case in 6,782 households, 82% of potential secondary cases were tested within 14 days, of which 17% tested positive as secondary cases, implying an attack rate of 17%. Among primary cases, those aged 0-24 were underrepresented when compared with the total population. We found an approximately linearly increasing relationship between attack rate and age. We investigated the transmission risk from primary cases by age, and found an increasing risk with age of primary cases for adults, while the risk seems to decrease with age for children.Conclusions Although there is an increasing attack rate and transmission risk of SARS-CoV-2 with age, children are also able to transmit SARS-CoV-2 within the household.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFrederik Plesner Lyngse: Independent Research Fund Denmark (Grant no. 9061-00035B.); Novo Nordisk Foundation (grant no. NNF17OC0026542); the Danish National Research Foundation through its grant (DNRF-134) to the Center for Economic Behavior and Inequality (CEBI) at the University of Copenhagen. Carsten Thure Kirkeby: None. Tariq Halasa: None. Viggo Andreasen: Carlsberg Foundation, Semper Ardens Research Project, CF20-0046. Robert Leo Skov: None. Tyra Grove Krause: None. Frederik Trier Møller: None. Kåre Mølbak: None.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Statens Serum Institut and The Danish Health Data Authority.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available through Statens Serum Institut and The Danish Health Data Authority.